W. Saber

发表

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

W. Wood, M. Aljurf, J. Szer, 2017, Cancer.

Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant.

M. Pasquini, M. Horowitz, Stephanie J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is Discontinuation of Antiplatelet Therapy after 6 Months Safe in Patients with Drug-Eluting Stents Undergoing Noncardiac Surgery?

Deepak L. Bhatt, D. Brotman, Ashish Aneja, 2006 .

Survival following allogeneic transplant in patients with myelofibrosis.

N. Kröger, M. Arcasoy, S. Verstovsek, 2020, Blood advances.

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Kyle M. Hebert, M. Pasquini, M. Horowitz, 2020, Biology of Blood and Marrow Transplantation.

Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee

W. Wood, N. Kröger, M. Perales, 2020, Biology of Blood and Marrow Transplantation.

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia.

M. Horowitz, S. Opie, W. Saber, 2012, Blood.

Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.

Christopher G. Kanakry, B. Sandmaier, C. Hourigan, 2021, Transplantation and cellular therapy.

Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study.

Deepak L. Bhatt, D. Brotman, Ashish Aneja, 2007, Journal of hospital medicine.

Neighborhood-Poverty and Pediatric Allogeneic Hematopoietic Cell Transplantation Outcomes: A CIBMTR Analysis.

W. Wood, M. Aljurf, A. Yoshimi, 2020, Blood.

Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens.

M. Horowitz, W. Saber, 2016, Hematology. American Society of Hematology. Education Program.

Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2017, The New England journal of medicine.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

M. Aljurf, J. Szer, R. Gale, 2021, Transplantation and cellular therapy.

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant

K. Hsu, Stephanie J. Lee, S. Spellman, 2020, Leukemia & lymphoma.

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients.

R. Vij, W. Wood, M. Aljurf, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

W. Wood, A. Gratwohl, M. Aljurf, 2020, Cancer.

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.

M. Aljurf, R. Gale, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)

J. Troy, W. Saber, K. Bylow, 2014, Current Hematologic Malignancy Reports.

Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #110

E. Leifer, F. Appelbaum, M. Horowitz, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

H. Deeg, E. Guinan, B. George, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

M. Aljurf, M. Pasquini, H. Lazarus, 2020, British journal of haematology.

Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome.

P. Hari, M. Pasquini, B. Shaw, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

S. Crawford, P. Veys, R. Champlin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

P. Hari, M. Pasquini, M. Horowitz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms

D. Kleiner, S. Bhatia, E. Engels, 2017 .

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

R. Gale, H. Khoury, U. Popat, 2018, Blood advances.

Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies

C. Cimminiello, M. Moia, G. Agnelli, 2011, Journal of thrombosis and haemostasis : JTH.

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.

M. Pasquini, Stephanie J. Lee, B. Shaw, 2022, Transplantation and cellular therapy.

Veno‐occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation

W. Saber, C. Duncan, F. Loberiza, 2021, Pediatric blood & cancer.

Prior Gemtuzumab Ozogamicin Exposure in Adults With Acute Myeloid Leukemia Does Not Increase Hepatic Veno-occlusive Disease Risk After Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis.

W. Saber, V. Ho, F. Loberiza, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis

W. Wood, D. Rizzieri, H. Lazarus, 2020 .

Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

H. Einsele, F. Baldanti, G. Fahle, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement

J. Vose, S. Montoto, P. Hari, 2013, British journal of haematology.

New cancers after autotransplantations for multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome.

A. Banerjee, P. Hari, M. Pasquini, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

Short Telomere Length Predicts Non-Relapse Mortality after Stem Cell Transplantation for Myelodysplastic Syndrome.

D. Neuberg, Suneet Agarwal, D. Steensma, 2020, Blood.

A 65-year-old factory worker with dyspnea on exertion and a normal chest x-ray.

R. Dweik, W. Saber, 2000, Cleveland Clinic journal of medicine.

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis

S. Chanock, H. Deeg, Jia Liu, 2022, Nature Communications.

Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation

J. Gerber, R. Aplenc, Yimei Li, 2018, Infection Control & Hospital Epidemiology.

Efficacy of a second allogeneic hematopoietic cell transplant in relapsed acute myeloid leukemia: results of a systematic review and meta-analysis.

M. Mohty, M. Aljurf, W. Saber, 2022, Transplantation and cellular therapy.

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

R. Vij, Lixin Yang, M. Aljurf, 2022, Haematologica.

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.

H. Deeg, P. Hari, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.

P. Richardson, M. Horowitz, B. Nejadnik, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphoma: working committee and data reporting after transplantation in lymphoma

P. Hari, S. Hashmi, W. Saber, 2015 .

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia

M. Baccarani, G. Rosti, S. Soverini, 2022, Leukemia.

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.

A. Krishnan, S. Lonial, R. Vij, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Flexible ureterorenoscopy (RIRS) vs. Mini- percutaneous nephrolithotomy (MINI-PCNL) for renal stones 20–30 mm a prospective randomized study

S. Elbashir, W. Saber, A. Sebaey, 2022, African Journal of Urology.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

B. Sandmaier, M. Aljurf, M. Tallman, 2017, Cancer.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, O. Ringdén, 2017, American journal of hematology.

Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

S. Zeger, G. Gui, C. Hourigan, 2022, medRxiv.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18–29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis

W. Wood, R. Sparapani, R. Gale, 2016 .

The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.

R. Vij, M. Aljurf, J. Szer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase.

H. Deeg, U. Popat, J. Capo-Chichi, 2020, Blood advances.

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

Y. Liu, M. Aljurf, J. Szer, 2020, Blood advances.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

E. Estey, B. Sandmaier, M. Krem, 2021, Bone Marrow Transplantation.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings.

A. D’Souza, W. Saber, L. Mau, 2020, Biology of Blood and Marrow Transplantation.

Perioperative medication management: a case-based review of general principles.

W. Saber, 2006, Cleveland Clinic journal of medicine.

Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

J. Bolaños-Meade, Yi-Bin Chen, J. Hansen, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2013, Blood.

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

P. Hari, M. Pasquini, M. Horowitz, 2018, Haematologica.

Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation

M. Aljurf, J. Szer, D. Niederwieser, 2020, Transplantation and Cellular Therapy.

Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202

A. Aviv, H. Katki, Tsung-Po Lai, 2022, Frontiers in Immunology.

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

P. Richardson, F. Baron, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Title : " Risk Score for Veno-occlusive Disease After Allogeneic Stem-Cell Transplant "

Marcelo, M. Horowitz, Stephanie J. Lee, 2017 .

Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens

J. Cortes, M. Aljurf, I. Lewis, 2014 .

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

S. Crawford, P. Veys, R. Champlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, D. Weisdorf, 2017, Cancer.

GVHD after HLA-matched sibling BMT or PBSCT: Comparison of North American Caucasian and Japanese Populations

Shahrukh, W. Wood, J. Kanda, 2016 .

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

M. Tallman, R. Gale, T. Shea, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases

Michael J. Eckrich, W. Wood, Zhezhen Jin, 2017, Haematologica.

Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia

A. Advani, M. Sekeres, Barbara Tripp, 2008, Leukemia & lymphoma.

Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis

P. Hari, M. Pasquini, A. D’Souza, 2015, Bone Marrow Transplantation.

Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.

P. Hari, M. Pasquini, A. D’Souza, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

P. Hari, M. Mohty, M. Aljurf, 2020, Hematology/oncology and stem cell therapy.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

P. Hari, M. Mohty, M. Aljurf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.

P. Hari, M. Pasquini, A. D’Souza, 2016, Clinical lymphoma, myeloma & leukemia.

Feasibility of Centralized Electronic Patient-Reported Outcome (ePRO) Collection By an Outcome Registry, a CIBMTR Study of Patients on the Centers for Medicaid & Medicare Coverage with Evidence Development (CMS CED) Myelodysplasia Protocol

M. Horowitz, J. Pidala, Stephanie J. Lee, 2020 .

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.

M. Norkin, A. Barrett, M. Boeckh, 2016, Blood.

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation

P. Hari, R. Moss, M. Pasquini, 2016, Case Reports in Medicine.

Alpha‐1‐antitrypsin for the treatment of steroid‐refractory acute gastrointestinal graft‐versus‐host disease

P. Hari, M. Pasquini, B. Shaw, 2017, American journal of hematology.

Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective

P. Hari, M. Pasquini, B. Shaw, 2018, Bone Marrow Transplantation.

Age is no Barrier for Adults undergoing HCT for AML in CR1: Contemporary CIBMTR Analysis

C. Hourigan, S. Farag, V. Bhatt, 2022, Bone Marrow Transplantation.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.

W. Wood, R. Sparapani, R. Gale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

B. Sandmaier, M. Horowitz, H. Khoury, 2017, Cancer.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

M. Horowitz, P. Armand, R. Soiffer, 2014, Blood.

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Commi

W. Wood, N. Kröger, M. Perales, 2020, Biology of Blood and Marrow Transplantation.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.

W. Wood, A. Nagler, M. Mohty, 2022, Transplantation and cellular therapy.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

A. Barrett, D. Kleiner, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012

H. Baldomero, M. Aljurf, D. Niederwieser, 2022, Bone Marrow Transplantation.

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

M. Horowitz, B. Shaw, S. Devine, 2020, Biology of Blood and Marrow Transplantation.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Urethroplasty with Lingual Mucosal Graft for Management of Long and Recurrent Strictures of the Anterior Urethra

W. Saber, Y. Farhat, S. Elgamal, 2008 .

HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis.

H. Chu, D. Weisdorf, A. Rashidi, 2019, Blood advances.

Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML.

A. Advani, M. Sekeres, Barbara Tripp, 2008, Leukemia research.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.

A. Ganser, G. Mufti, N. Kröger, 2017, Blood.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.

J. Klein, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

M. Horowitz, R. Soiffer, M. Kalaycio, 2013 .

The clinical and functional effects of TERT variants in myelodysplastic syndrome.

D. Neuberg, J. Garber, Suneet Agarwal, 2021, Blood.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes

S. Spellman, A. Nazha, Yung-Tsi Bolon, 2021, Transplantation and cellular therapy.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

The clinical and functional effects of TERT variants in myelodysplastic syndrome

D. Neuberg, J. Garber, Suneet Agarwal, 2021, bioRxiv.

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

N. Kröger, J. Snowden, H. Baldomero, 2021, Haematologica.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

W. Wood, K. Sullivan, M. Aljurf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A case of engraftment syndrome in the medical intensive care unit

W. Saber, Joy Tang, J. Jerkins, 2018 .

Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia

D. Vanness, W. Saber, L. Mau, 2019, JNCI cancer spectrum.

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft

P. Hari, M. Pasquini, M. Horowitz, 2017, Bone Marrow Transplantation.

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).

J. Cortes, M. Horowitz, M. Kalaycio, 2013, Blood.

Myelodysplastic syndromes in the United States: an update for clinicians

J. Troy, W. Saber, J. Geyer, 2014, Annals of medicine.

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

Mei-Jie Zhang, Wael Saber, M. Perales, 2016, Haematologica.

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Purushottam W. Laud, J. Wingard, K. Syrjala, 2018, Haematologica.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma

P. Hari, M. Pasquini, M. Horowitz, 2015, Bone Marrow Transplantation.

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation

P. Hari, M. Pasquini, X. Zhong, 2015, Bone Marrow Transplantation.

Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis

I. Yakoub-Agha, D. Mclornan, A. Radujkovic, 2022, British journal of haematology.

Tocilizumab for the treatment of steroid refractory graft-versus-host disease.

P. Hari, M. Pasquini, W. Saber, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

M. Pasquini, U. Popat, Xiaochun Zhu, 2014 .

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

S. Zeger, G. Gui, C. Hourigan, 2023, JAMA.

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis From The CIBMTR

M. Aljurf, Stephanie J. Lee, S. Spellman, 2015 .

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

E. Leifer, P. Westervelt, F. Appelbaum, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

E. Leifer, P. Westervelt, F. Appelbaum, 2020, Transplantation and Cellular Therapy.

Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach

D. Vanness, N. Majhail, W. Saber, 2020, PharmacoEconomics.

Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries

Ibrahim N. Muhsen, W. Wood, M. Aljurf, 2019, Bone Marrow Transplantation.

Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.

P. Hari, M. Pasquini, B. Shaw, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.

D. Vanness, N. Majhail, W. Saber, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis

N. Ueno, M. Bishop, H. Lazarus, 2012, Bone Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplant Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease.

L. Krishnamurti, Yung-Tsi Bolon, W. Saber, 2021, Transplantation and cellular therapy.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.

W. Wood, M. Horowitz, K. Syrjala, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and Lymphoma

P. Hari, M. Pasquini, M. Horowitz, 2014 .

Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

G. Gui, C. Hourigan, S. Spellman, 2022, Journal of Clinical Oncology.

Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.

P. Hari, A. Szabo, A. D’Souza, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.

W. Wood, J. Kanda, Y. Kanda, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

D. Neuberg, S. Sallan, J. Bergeron, 2016, American journal of hematology.

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

M. Boeckh, J. Wingard, H. Lazarus, 2016, Bone Marrow Transplantation.

Administrative Claims Data for Economic Analyses in Hematopoietic Cell Transplantation: Challenges and Opportunities.

D. Vanness, N. Majhail, W. Saber, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

TRANSPLANTATION Validation and re fi nement of the Disease Risk Index for allogeneic stem cell transplantation

M. Horowitz, P. Armand, R. Soiffer, 2014 .

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study

M. Perales, S. Putta, W. Saber, 2022, Transplantation and cellular therapy.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Germline predisposition variants occur in myelodysplastic syndrome patients of all ages.

S. Spellman, R. Sobecks, L. Godley, 2022, Blood.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

J Wagner, F. Awan, M. Krem, 2022, Transplantation and cellular therapy.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.

N. Kröger, M. Perales, M. Mohty, 2021, Transplantation and cellular therapy.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine/busulfan conditioning based allogeneic hematopoietic cell transplantation for myelofibrosis: Role of ruxolitinib in improving survival outcomes.

P. Hari, M. Pasquini, B. Shaw, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Genetic Mutations on the Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia with Antecedent Myeloproliferative Neoplasm

U. Popat, J. Capo-Chichi, K. Ahn, 2020 .

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes

M. Pasquini, A. Wickrema, U. Popat, 2016, Haematologica.

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.

B. Sandmaier, R. Gale, H. Khoury, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

W. Wood, H. Jim, J. Wingard, 2022, Transplantation and cellular therapy.

Patient and provider preferences: Treatment summary and survivorship care plans after hematopoietic cell transplant.

J. Wingard, K. Syrjala, N. Majhail, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

H. Deeg, M. Perales, H. Kluin-Nelemans, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

R. Vij, M. Aljurf, R. Gale, 2022, JAMA oncology.

Pre-transplant marital status and hematopoietic cell transplantation outcomes.

W. Wood, K. Sullivan, M. Aljurf, 2020, Current oncology.

Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

M. Aljurf, J. Szer, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

F. Baron, M. Krem, C. Hourigan, 2021, Bone Marrow Transplantation.

Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

U. Popat, R. Sobecks, W. Saber, 2018, Blood.

Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research.

M. Pasquini, B. Shaw, K. Flynn, 2023, Transplantation and cellular therapy.

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.

B. George, M. Grunwald, D. Weisdorf, 2021, Blood advances.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

B. Sandmaier, M. Perales, A. Nagler, 2020, Blood advances.

The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children.

M. Horowitz, W. Saber, Mei-Jie Zhang, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.

P. Greenberg, M. Horowitz, B. Logan, 2019, JAMA oncology.

Trends in Allogeneic Hematopoietic Cell Transplantation Utilization And Estimated Unmet Need among Medicare Beneficiaries with Acute Myeloid Leukemia.

N. Khera, W. Saber, L. Mau, 2021, Transplantation and cellular therapy.

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis.

W. Wood, M. Aljurf, H. Lazarus, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

R. Larson, B. Sandmaier, F. Appelbaum, 2021, Leukemia.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report

M. Davids, U. Popat, K. Ahn, 2017 .

Transseptal approach for mitral valve surgery. A safe alternative when the need calls.

W. Saber, E. Mostafa, M. Aly, 1993, Texas Heart Institute journal.

Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)

P. Hari, M. Pasquini, M. Horowitz, 2016 .

Stratification of Allogeneic Hematopoietic Cell Transplant Patients by Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Stephanie J. Lee, A. Artz, A. Loren, 2017 .

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

D. Allan, C. Bredeson, W. Saber, 2022, Blood.

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.

D. Neuberg, Suneet Agarwal, D. Steensma, 2020, Blood.

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.

W. Wood, H. Jim, J. Wingard, 2023, Transplantation and cellular therapy.

The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization.

W. Wood, D. Rizzieri, H. Lazarus, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis.

W. Wood, M. Aljurf, H. Lazarus, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute Gvhd Diagnosis and Adjudication in a Multicenter Trial – a Report from the BMT CTN 1202 Biorepository Study

Yi-Bin Chen, J. Hansen, W. Saber, 2019, Biology of Blood and Marrow Transplantation.

Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials.

S. Crawford, M. Pasquini, S. Giralt, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

D. Neuberg, S. Sallan, B. Sandmaier, 2014 .

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

D. Neuberg, B. Ebert, K. Hsu, 2016 .

Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.

W. Wood, L. Akard, B. Logan, 2023, Transplantation and cellular therapy.

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.

C. Hourigan, M. Aljurf, C. Bredeson, 2023, Transplantation and cellular therapy.

Stephanie J. Lee, B. Shaw, K. Flynn, 2022, American journal of hematology.

Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

C. Hourigan, C. Bredeson, D. Marks, 2023, Transplantation and cellular therapy.

Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].